Showing results (21-30 of 10,794) with videos related to

Sort By:
Pageof 1,080
Journal of Biopharmaceutical Statistics|June 23, 2022
Bayesian Additive Regression Trees (BART) with covariate adjusted borrowing in subgroup analysesJane Pan, Veronica Bunn, Bradley Hupf, et al.
Clinical Trials (London, England)|July 8, 2025
BARD: A seamless two-stage dose optimization design integrating backfill and adaptive randomizationYixuan Zhao, Rachael Liu, Jianchang Lin, et al.
Pharmaceutical Statistics|August 1, 2025
A Flexible Seamless Phase 2/3 Design With Biomarker-Driven Subgroup Enrichment and Sample Size Re-EstimationZizhong Tian, Liwen Wu, Rachael Liu, et al.
Statistics in Medicine|October 20, 2023
BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpointsDehua Bi, Meizi Liu, Jianchang Lin, et al.
Statistics in Medicine|July 26, 2023
Estimation of conditional power in the presence of auxiliary dataXin Li, Godwin Yung, Jianchang Lin, et al.
Contemporary Clinical Trials|September 17, 2020
Flexible Bayesian subgroup analysis in early and confirmatory trialsVeronica Bunn, Rachael Liu, Junjing Lin, et al.
Journal of Biopharmaceutical Statistics|September 21, 2020
TEPI-2 and UBI: designs for optimal immuno-oncology and cell therapy dose finding with toxicity and efficacyPin Li, Rachael Liu, Jianchang Lin, et al.
Journal of Biopharmaceutical Statistics|August 24, 2022
PMED: Optimal Bayesian Platform Trial Design with Multiple EndpointsTian He, Rachael Liu, Meizi Liu, et al.
Journal of Biopharmaceutical Statistics|November 28, 2025
M-DODII: Bayesian dose optimization design for randomized phase II study with multiple indicationsSasha Amdur Kravets, Ziji Yu, Rachael Liu, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 12, 2018
Insights on Peritoneal Dialysis in ChinaMartin Wilkie, Simon Davies
Pageof 1,080